Lupin Limited has informed the Exchange regarding a press release dated March 23, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets.".
Lupin Limited has informed the Exchange regarding a press release dated March 23, 2023, titled "Lupin Receives Tentative Approval from U.S. FDA for Obeticholic Acid Tablets.".